Skip to main content
Premium Trial:

Request an Annual Quote

Time to Polish Those Resumes in Foster City

Yesterday's news that Invitrogen is buying Applied Biosystems for $6.7 billion stirred tremendous interest from the community. Our sister website GenomeWeb Daily News reports that "the deal would be the largest in the life sciences tools market since Thermo Electron bought Fisher Scientific for $10.6 billion in 2006." Invitrogen CEO Greg Lucier will head up the whole company, and current Applera CEO Tony White will be a consultant for five years once the deal is approved.

Over at Biofind's rumor mill, a post wonders "how long it will be before Invitrogen starts handing ABI people pink slips."

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.